Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?

Background: in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NET), the mTOR inhibitor everolimus is associated with significant improvement in progression-free survival (PFS). This study evaluated the lesional asphericity (ASP) in pretherapeutic somatostatin receptor (SSR) imaging...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diagnostics (Basel)
Main Authors: Wetz, Christoph, Rogasch, Julian, Genseke, Philipp, Schatka, Imke, Furth, Christian, Kreissl, Michael, Jann, Henning, Venerito, Marino, Amthauer, Holger
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7554807/
https://ncbi.nlm.nih.gov/pubmed/32971877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10090732
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker